These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33624507)

  • 1. Associations Between Blood Biomarkers, Cardiac Function, and Adverse Outcome in a Young Fontan Cohort.
    van den Bosch E; Bossers SSM; Kamphuis VP; Boersma E; Roos-Hesselink JW; Breur JMPJ; Ten Harkel ADJ; Kapusta L; Bartelds B; Roest AAW; Kuipers IM; Blom NA; Koopman LP; Helbing WA
    J Am Heart Assoc; 2021 Feb; 10(5):e015022. PubMed ID: 33624507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF-15 (Growth Differentiation Factor 15) Is Associated With Hospitalization and Mortality in Patients With a Fontan Circulation.
    Meyer SL; Wolff D; Ridderbos FS; Eshuis G; Hillege H; Willems TP; Ebels T; van Melle JP; Berger RMF
    J Am Heart Assoc; 2020 May; 9(10):e015521. PubMed ID: 32384007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between blood biomarkers, cardiac function and adverse outcome in a young tetralogy of Fallot cohort.
    van den Bosch E; van Genuchten WJ; Luijnenburg SE; Duppen N; Kamphuis VP; Roos-Hesselink JW; Bartelds B; Roest AAW; Breur JMPJ; Blom NA; Boersma E; Koopman LP; Helbing WA
    Int J Cardiol; 2022 Aug; 361():31-37. PubMed ID: 35487320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation.
    Opotowsky AR; Baraona F; Owumi J; Loukas B; Singh MN; Valente AM; Wu F; Cheng S; Veldtman G; Rimm EB; Landzberg MJ
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26755550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of heart failure and death in an adult population of Fontan patients.
    Sieweke JT; Haghikia A; Riehle C; Klages C; Akin M; König T; Zwadlo C; Treptau J; Schäfer A; Bauersachs J; Westhoff-Bleck M
    Cardiol Young; 2019 May; 29(5):602-609. PubMed ID: 31036097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Effects of Percutaneous Fenestration Following the Fontan Procedure in Adult Patients with Congenital Univentricular Heart.
    Smaś-Suska M; Róg B; Weryński P; Płazak W; Komar M; Olszowska M; Podolec P; Tomkiewicz-Pająk L
    Med Sci Monit; 2018 May; 24():3506-3513. PubMed ID: 29802801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor 15--an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts.
    Raedle-Hurst TM; Koenigstein K; Gruenhage F; Raedle J; Herrmann E; Abdul-Khaliq H
    Am Heart J; 2010 Dec; 160(6):1105-12. PubMed ID: 21146665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Importance of Fontan Circuit Thrombus in the Adult Population: Significant Association With Increased Risk of Cardiovascular Events.
    Sathananthan G; Johal N; Verma T; Sandhu S; Chakrabarti S; Riahi M; Human D; Leipsic J; Grewal J
    Can J Cardiol; 2019 Dec; 35(12):1807-1814. PubMed ID: 31813509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Outcomes of Patients With Single Ventricle After the Fontan Procedure.
    Atz AM; Zak V; Mahony L; Uzark K; D'agincourt N; Goldberg DJ; Williams RV; Breitbart RE; Colan SD; Burns KM; Margossian R; Henderson HT; Korsin R; Marino BS; Daniels K; McCrindle BW;
    J Am Coll Cardiol; 2017 Jun; 69(22):2735-2744. PubMed ID: 28571639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fontan-Associated Dyslipidemia.
    Lubert AM; Alsaied T; Palermo JJ; Anwar N; Urbina EM; Brown NM; Alexander C; Almeneisi H; Wu F; Leventhal AR; Aldweib N; Mendelson M; Opotowsky AR
    J Am Heart Assoc; 2021 Apr; 10(7):e019578. PubMed ID: 33787283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of N-terminal pro brain natriuretic peptide levels in different types of Fontan circulation.
    Heck PB; Müller J; Weber R; Hager A
    Eur J Heart Fail; 2013 Jun; 15(6):644-9. PubMed ID: 23610138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
    Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
    JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival data and predictors of functional outcome an average of 15 years after the Fontan procedure: the pediatric heart network Fontan cohort.
    Atz AM; Zak V; Mahony L; Uzark K; Shrader P; Gallagher D; Paridon SM; Williams RV; Breitbart RE; Colan SD; Kaltman JR; Margossian R; Pasquali SK; Allen K; Lai WW; Korsin R; Marino BS; Mirarchi N; McCrindle BW;
    Congenit Heart Dis; 2015; 10(1):E30-42. PubMed ID: 24934522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, Predictors, and Mortality in Patients With Liver Cancer After Fontan Operation.
    Ohuchi H; Hayama Y; Nakajima K; Kurosaki K; Shiraishi I; Nakai M
    J Am Heart Assoc; 2021 Feb; 10(4):e016617. PubMed ID: 33538186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
    Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
    Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolic Risk After Atriopulmonary, Lateral Tunnel, and Extracardiac Conduit Fontan Surgery.
    Deshaies C; Hamilton RM; Shohoudi A; Trottier H; Poirier N; Aboulhosn J; Broberg CS; Cohen S; Cook S; Dore A; Fernandes SM; Fournier A; Kay J; Mondésert B; Mongeon FP; Opotowsky AR; Proietti A; Ting J; Zaidi A; Khairy P;
    J Am Coll Cardiol; 2019 Aug; 74(8):1071-1081. PubMed ID: 31439217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison Between Echocardiography and Cardiac Magnetic Resonance Imaging in Predicting Transplant-Free Survival After the Fontan Operation.
    Ghelani SJ; Harrild DM; Gauvreau K; Geva T; Rathod RH
    Am J Cardiol; 2015 Oct; 116(7):1132-8. PubMed ID: 26251003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes in Adolescents and Adults After the Fontan Procedure.
    Dennis M; Zannino D; du Plessis K; Bullock A; Disney PJS; Radford DJ; Hornung T; Grigg L; Cordina R; d'Udekem Y; Celermajer DS
    J Am Coll Cardiol; 2018 Mar; 71(9):1009-1017. PubMed ID: 29495980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inefficient Ventriculoarterial Coupling in Fontan Patients: A Cardiac Magnetic Resonance Study.
    Godfrey ME; Rathod RH; Keenan E; Gauvreau K; Powell AJ; Geva T; Prakash A
    Pediatr Cardiol; 2018 Apr; 39(4):763-773. PubMed ID: 29404642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.